Surgical management of intraductal papillary mucinous neoplasm with main duct involvement: an international expert survey and case‐vignette study

[1]  Marco Marc Lianne Marco J Djuna L Thomas M Jeanin E Mark Del Chiaro Besselink Scholten Bruno Cahen G.  European evidence-based guidelines on pancreatic cystic neoplasms , 2018, Gut.

[2]  Jin‐Young Jang,et al.  of the pancreas , 2017 .

[3]  P. Fockens,et al.  Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome. , 2017, Gastrointestinal endoscopy.

[4]  M. Nikiforova,et al.  American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. , 2016, Gastrointestinal endoscopy.

[5]  M. Kanda,et al.  Comparison of the international consensus guidelines for predicting malignancy in intraductal papillary mucinous neoplasms. , 2016, Surgery.

[6]  E. Furth,et al.  Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  K. Lillemoe,et al.  Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis. , 2015, Journal of the American College of Surgeons.

[8]  P. Moayyedi,et al.  American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. , 2015, Gastroenterology.

[9]  L. Buscail,et al.  Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas. , 2015, World journal of gastroenterology.

[10]  T. Ohtsuka,et al.  Long-Term Outcomes After Total Pancreatectomy: Special Reference to Survivors’ Living Conditions and Quality of Life , 2015, World Journal of Surgery.

[11]  M. Falconi,et al.  Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs , 2014, Gastroenterology research and practice.

[12]  D. Mirza,et al.  How severe is diabetes after total pancreatectomy? A case-matched analysis. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  Jin‐Young Jang,et al.  Long-term Prospective Cohort Study of Patients Undergoing Pancreatectomy for Intraductal Papillary Mucinous Neoplasm of the Pancreas: Implications for Postoperative Surveillance , 2014, Annals of surgery.

[14]  M. Al-Haddad,et al.  Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients. , 2014, Journal of the American College of Surgeons.

[15]  J. Chabot,et al.  Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection. , 2014, The Journal of surgical research.

[16]  T. Ohtsuka,et al.  Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. , 2012, American journal of surgery.

[17]  G. Honda,et al.  Predictors of Malignancy and Natural History of Main-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas , 2011, Pancreas.

[18]  N. Kawada,et al.  A Natural Course of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas With Lower Likelihood of Malignancy , 2010, Pancreas.

[19]  M. Mino‐Kenudson,et al.  Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  Song-Cheol Kim,et al.  Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. , 2008, Journal of hepato-biliary-pancreatic surgery.

[21]  H. Friess,et al.  Is There Still a Role for Total Pancreatectomy? , 2007, Annals of surgery.

[22]  Joshua A. Waters,et al.  Intraductal Papillary Mucinous Neoplasms: Predictors of Malignant and Invasive Pathology , 2007, Annals of surgery.

[23]  S. Chari,et al.  International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.

[24]  P. Bedossa,et al.  Frozen Sectioning of the Pancreatic Cut Surface During Resection of Intraductal Papillary Mucinous Neoplasms of the Pancreas Is Useful and Reliable: A Prospective Evaluation , 2005, Annals of surgery.

[25]  W. Harmsen,et al.  Quality-of-life after total pancreatectomy: Is it really that bad on long-term follow-up? , 2005, Journal of Gastrointestinal Surgery.

[26]  Michio Shimizu,et al.  An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms , 2004, The American journal of surgical pathology.

[27]  C. Bassi,et al.  Main-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinical Predictors of Malignancy and Long-term Survival Following Resection , 2004, Annals of surgery.